11 | Matrix Metalloproteinases (MMPs)IBA
06/2019
-
01/2009 |
9 | Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2015
-
03/2007 |
8 | Free RadicalsIBA
02/2012
-
08/2002 |
7 | CytokinesIBA
05/2022
-
01/2009 |
6 | Neuroprotective AgentsIBA
01/2019
-
04/2006 |
6 | Proteins (Proteins, Gene)FDA Link
01/2019
-
08/2003 |
6 | Caspase 3 (Caspase-3)IBA
02/2012
-
03/2007 |
5 | Retinaldehyde (Retinal)IBA
01/2020
-
01/2017 |
5 | Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
02/2012
-
04/2006 |
4 | Immunoglobulin E (IgE)IBA
05/2022
-
01/2013 |
4 | OvalbuminIBA
05/2022
-
01/2010 |
4 | LipopolysaccharidesIBA
06/2019
-
08/2002 |
4 | Adenosine Diphosphate (ADP)IBA
06/2013
-
04/2003 |
4 | Histone Deacetylase InhibitorsIBA
04/2012
-
05/2011 |
4 | Fluorescein (Funduscein)FDA LinkGeneric
10/2005
-
05/2003 |
3 | Interleukin-10 (Interleukin 10)IBA
05/2022
-
01/2010 |
3 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2021
-
01/2013 |
3 | Matrix Metalloproteinase 9 (Gelatinase B)IBA
06/2019
-
06/2017 |
3 | Histone Deacetylases (Histone Deacetylase)IBA
02/2012
-
05/2011 |
3 | theasinensin AIBA
02/2012
-
05/2011 |
3 | Therapeutic UsesIBA
04/2011
-
05/2004 |
3 | SolventsIBA
04/2011
-
05/2004 |
3 | tetramethylpyrazineIBA
03/2007
-
04/2006 |
3 | AntioxidantsIBA
03/2007
-
04/2003 |
2 | Interleukin-13IBA
05/2022
-
01/2013 |
2 | Interleukin-5 (Interleukin 5)IBA
05/2022
-
01/2013 |
2 | Retinal Pigments (Pigments, Visual)IBA
04/2019
-
01/2018 |
2 | 2,3,7,7a- tetrahydro- 3- hydroxy- 7- methyl- 2- (prop- 1- en- 1- yl)- 5H- furo(3,4- b)pyran- 5- oneIBA
03/2019
-
01/2018 |
2 | ethyl acetateIBA
03/2018
-
01/2017 |
2 | Anti-Allergic Agents (Antiallergic Agents)IBA
10/2017
-
01/2016 |
2 | imperatorinIBA
10/2017
-
01/2016 |
2 | Coloring Agents (Dyes)IBA
10/2015
-
08/2002 |
2 | SurvivinIBA
04/2014
-
02/2012 |
2 | andrographolideIBA
09/2013
-
12/2011 |
2 | Midazolam (Versed)FDA LinkGeneric
04/2013
-
03/2004 |
2 | Plasminogen Activator Inhibitor 1IBA
04/2012
-
06/2009 |
2 | trichostatin A (A 300)IBA
02/2012
-
05/2011 |
2 | sesamolIBA
05/2011
-
12/2010 |
2 | Messenger RNA (mRNA)IBA
01/2009
-
03/2007 |
2 | Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2009
-
08/2002 |
2 | Amyloid beta-PeptidesIBA
07/2008
-
02/2008 |
2 | 3-nitrotyrosineIBA
03/2007
-
04/2006 |
2 | Oxygen (Dioxygen)IBA
09/2006
-
09/2002 |
2 | Dihydrotachysterol (AT 10)IBA
04/2006
-
09/2002 |
2 | Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
10/2005
-
06/2005 |
2 | LycopeneIBA
10/2005
-
05/2004 |
2 | Magnesium Sulfate (Sulfate, Magnesium)FDA LinkGeneric
01/2004
-
05/2003 |
1 | acteosideIBA
05/2022 |
1 | Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
05/2022 |
1 | Interleukin-4 (Interleukin 4)IBA
05/2022 |
1 | indolineIBA
07/2021 |
1 | pro-matrix metalloproteinase 9IBA
04/2021 |
1 | EicosanoidsIBA
06/2020 |
1 | AlbuminsIBA
01/2020 |
1 | 11,12-epoxy-5,8,14-eicosatrienoic acidIBA
01/2020 |
1 | Tight Junction ProteinsIBA
01/2020 |